Schering Plough Corp (SGP-N) Stock Predictions - Stockchase
WATCH LIST
16
Schering Plough Corp (SGP-N)

ON STOCKCHASE SINCE Apr 2001

biotechnology/pharmaceutical

Schering Plough Corp

SGP-N

0 watching          
Join the Discussion

Schering Plough Corp (SGP-N) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about SGP-N



  • All
  • Filtered
Signal Opinion Expert
TOP PICK
Schering Plough Corp(SGP-N) 

August 19, 2009

Merging with Merck (MRK-N). Combination will create a very strong pipeline of products, which for many years will have a good growth profile. It will merge short to mid cycle products with longer-term type products and thinks there are significant synergy type benefits. You could also own Merk but this is a discounted way of playing this. (See also MRK-N.)
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Merging with Merck (MRK-N). Combination will create a very strong pipeline of products, which for many years will have a good growth profile. It will merge short to mid cycle products with longer-term type products and thinks there are significant synergy type benefits. You could also own Merk but this is a discounted way of playing this. (See also MRK-N.)
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Ara Nalbandian

Portfolio , Highwater Capital Ma...

Price Price
$27.650
Owned Owned
Yes

DON'T BUY
Smaller US drug manufacturer. Has been hit along with the others. A big wall of branded drugs will be falling off and become generic in 2010 and 2011. Has also had negative news on some of its drug development. Decent pipeline of new drugs. Expecting volatility while leading up to the election. (See Top Picks.)
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Smaller US drug manufacturer. Has been hit along with the others. A big wall of branded drugs will be falling off and become generic in 2010 and 2011. Has also had negative news on some of its drug development. Decent pipeline of new drugs. Expecting volatility while leading up to the election. (See Top Picks.)
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Andrew Guy, CFA

Portfolio , Sentry Select Capita...

Price Price
$19.910
Owned Owned
Unknown

DON'T BUY
Drugs in general have been very poor performers. This company had its fortunes tied to one new drug and that things were happening to it. He can see no catalyst that would make him buy this.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Drugs in general have been very poor performers. This company had its fortunes tied to one new drug and that things were happening to it. He can see no catalyst that would make him buy this.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$17.010
Owned Owned
No

TOP PICK
Very well managed but has run into all kinds of problems in the last 3 or 4 months stemming from one of their major products Vitorin, which they market in a joint venture with Merck. If you value the company on sales and you give zero sales to Vitorin, you are getting the same multiple levels as the other pharmaceutical companies. Great pipeline. New drug coming out in May or June to treat paralysis.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Very well managed but has run into all kinds of problems in the last 3 or 4 months stemming from one of their major products Vitorin, which they market in a joint venture with Merck. If you value the company on sales and you give zero sales to Vitorin, you are getting the same multiple levels as the other pharmaceutical companies. Great pipeline. New drug coming out in May or June to treat paralysis.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Don Lato

President, Padlock Investment M...

Price Price
$16.600
Owned Owned
Yes

TOP PICK
Schering Plough Corp(SGP-N) 

August 13, 2004

(Top Sell) With rising interest rates and high oil prices and slowing earnings growth can create some problems.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(Top Sell) With rising interest rates and high oil prices and slowing earnings growth can create some problems.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Stovall

Chief Inve, Wood Asset Managemen...

Price Price
$17.860
Owned Owned
No

DON'T BUY
Schering Plough Corp(SGP-N) 

September 8, 2003

Has been a basket case. Management issues. Could drop further.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has been a basket case. Management issues. Could drop further.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Paul O'Neil

Portfolio , KBSH Capital Mngmnt...

Price Price
$15.550
Owned Owned
No

DON'T BUY
The drug Clariton will be going generic. At fair value now.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
The drug Clariton will be going generic. At fair value now.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$17.040
Owned Owned
Unknown

DON'T BUY
Have had a lot of difficulties. Their drug Clariton came off patent allowing competitors in. The new CEO has a good reputation. Have to see a big improvement in their drug pipeline.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Have had a lot of difficulties. Their drug Clariton came off patent allowing competitors in. The new CEO has a good reputation. Have to see a big improvement in their drug pipeline.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brad Willock

Vice Presi, RBC Asset Management...

Price Price
$17.810
Owned Owned
Unknown

DON'T BUY
Schering Plough Corp(SGP-N) 

January 13, 2003

Prefers Pfizer.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Prefers Pfizer.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Neil Murdock

Executive , AIC Limited...

Price Price
$23.680
Owned Owned
Unknown

BUY
Clariton has moved from a prescription drug in the US to an over the counter one, but their newer drug will be a prescription, meaning larger margins. Possible takeover.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Clariton has moved from a prescription drug in the US to an over the counter one, but their newer drug will be a prescription, meaning larger margins. Possible takeover.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
John Sinkins, C

Senior Por, Sentry Select Capita...

Price Price
$29.250
Owned Owned
Unknown

BUY
Schering Plough Corp(SGP-N) 

February 21, 2002

Great sector. Had a tough year. Getting cleaned up now. Good pipeline. Good price.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Great sector. Had a tough year. Getting cleaned up now. Good pipeline. Good price.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Neil Murdock

Executive , AIC Limited...

Price Price
$34.000
Owned Owned
Unknown

DON'T BUY
Schering Plough Corp(SGP-N) 

January 30, 2002

Broke through a technical base. Generics are giving some tough competition.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Broke through a technical base. Generics are giving some tough competition.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$33.330
Owned Owned
Unknown

TOP PICK
Schering Plough Corp(SGP-N) 

January 8, 2002

FDA problems have been cleared up. Good pipeline. 21 X earnings.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
FDA problems have been cleared up. Good pipeline. 21 X earnings.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jeff Morrison

Portfolio , Bisset American Equi...

Price Price
$34.430
Owned Owned
Unknown

DON'T BUY
Schering Plough Corp(SGP-N) 

September 7, 2001

FDA has closed their factory at times. Cheap. Could be a buyout. Not a fan.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
FDA has closed their factory at times. Cheap. Could be a buyout. Not a fan.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$36.740
Owned Owned
Unknown

BUY
Schering Plough Corp(SGP-N) 

August 14, 2001

Good sector to be in.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Good sector to be in.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Neil Murdock

Executive , AIC Limited...

Price Price
$38.410
Owned Owned
Unknown

Showing 1 to 15 of 16 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days